Regarding to the differences highlighted between colorectal and breast cancer patients, according to Kobayashi and Huang, colorectal cancer patients have higher IL-6 serum level, which in turn could lead to delayed hypersensitivity AEs (Kobayashi et al., 2013; Huang et al., 2014). Here, IL6 is linked to colorectal cancer.